Search results
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 4 days agoThe 16 advisors did not vote on whether to favor the original JN.1 variant or one of its successors...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 2 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 2 days agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Colorado Springs Gazette· 6 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 4 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Associated Press via Yahoo News· 4 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 2 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
COVID shots should target JN.1 variant in 2024-25 campaign, US FDA says
Reuters· 2 days agoThe U.S. Food and Drug Administration on Friday advised COVID-19 vaccine manufacturers that new...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 2 days agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...